abacus trial: preoperative atezolizumab in urothelial carcinoma
Published 6 years ago • 244 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
2:30
abacus updates: positive results for preoperative atezolizumab in bladder cancer
-
2:52
pd-l1 and tmb as biomarkers in the imvigor211 trial of atezolizumab vs. chemo for bladder cancer
-
1:52
can atezolizumab succeed where bcg fails in bladder cancer?
-
3:00
atezolizumab limits disease progression for metastatic urothelial bladder cancer
-
3:06
urothelial carcinoma trial updates from asco 2018
-
1:13
saul analysis: atezolizumab in urothelial carcinoma patients
-
5:03
atezolizumab with ebrt for bladder preservation in mibc
-
2:54
a 6-factor prognostic model for urothelial carcinoma patients receiving atezolizumab
-
2:57
phase 3 imvigor130 results: atezolizumab in untreated metastatic urothelial carcinoma
-
1:47
atezolizumab in urothelial bladder cancer
-
1:25
dr. sonpavde on the next steps for atezolizumab in urothelial carcinoma
-
1:20
dr. rosenberg on future use of atezolizumab in bladder cancer
-
2:08
dr. david nanus on atezolizumab for urothelial bladder cancer
-
7:05
the fda approval of atezolizumab in bladder cancer
-
1:17
recent advances in the treatment of upper tract urothelial carcinoma
-
0:50
dr. petrylak on atezolizumab in bladder cancer
-
3:13
frontline atezolizumab for advanced bladder cancer
-
2:35
urothelial carcinoma treatment: the future
-
1:10
dr. steinberg on the fda approval of atezolizumab in bladder cancer